Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
Crossref DOI link: https://doi.org/10.1007/s40261-016-0456-1
Published Online: 2016-09-01
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lackey, Philip
Mills, Anthony
Carpio, Felix
Hsu, Ricky
DeJesus, Edwin
Pierone, Gerald
Henegar, Cassidy
Fusco, Jennifer
Fusco, Gregory
Wohlfeiler, Mike
Funding for this research was provided by:
ViiV Healthcare
License valid from 2016-09-01